https://medical-tribune.co.jp/news/2016/0902504563/
The reduction of transition to dialysis from diabetic nephropathy has become an important social issue. The Japan Society for the Prevention of Severe Cases of Chronic Diseases (JMAP) held a summer seminar on August 4 in Tokyo, which has long emphasized the importance of this issue and has been practicing it in various parts of Japan. The presentation was given by Takenori Sakai of the Department of Internal Medicine, Municipal Yawatahama General Hospital (Ehime Prefecture), who introduced the latest outcomes of the JMAP system, which is characterized by: 1) identification of high-risk cases using disease control MAP and ΔeGFR, 2) thorough patient guidance centered on salt reduction, and 3) utilization of GLP-1 receptor agonists that are expected to have a renoprotective action. (Related article: GLP-1 receptor agonist) (Related article: GLP-1 Receptor Agonist Proven Effective in Dialysis Prevention)
...If you are a member, please click here to login.
Click here to register as a new member.
Physician
Other Medical Professionals
Medical Tribune offers free access to all content and a points program for physicians.
Related Tags.
#General Internal Medicine#Diabetes and Endocrine Disorders#Nephrology#Other National Associations#Community Medicine#Diabetes#Diabetes Medications#Dialysis
Recommended Stories For You
GLP-1 Receptor Agonist Response to Dialysis Prophylaxis 2016.09.02
Comment function is for physician members only
Viewing and writing comments is restricted to physician members only.
Click here to register as a new member.
0 コメント:
コメントを投稿